NRC Health (NRC) stock
NRCNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/3078% above fair value
$25.89−0.44 (-1.69%)
Close on Nov 17, 2026Market cap $572.57MP/E –Yield 2.01%
NRC Health operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
NRC Health's operating cash flow for the twelve months ending Jun 30, 2026 was $29.51M, up 38.5% year over year. For fiscal 2025 it was $26.45M, down 23.6% from the year before. Over ten years it grew 1.9% a year on average. The highest annual figure on record is $46.34M in fiscal 2021.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $26.45M | -23.6% |
| FY2024 | Dec 31, 2024 | $34.63M | -9.2% |
| FY2023 | Dec 31, 2023 | $38.11M | +5.1% |
| FY2022 | Dec 31, 2022 | $36.27M | -21.7% |
| FY2021 | Dec 31, 2021 | $46.34M | +14.0% |
| FY2020 | Dec 31, 2020 | $40.64M | -0.7% |
| FY2019 | Dec 31, 2019 | $40.92M | +2.7% |
| FY2018 | Dec 31, 2018 | $39.85M | +41.9% |
| FY2017 | Dec 31, 2017 | $28.09M | +4.6% |
| FY2016 | Dec 31, 2016 | $26.84M | +22.6% |
| FY2015 | Dec 31, 2015 | $21.89M | -16.5% |
| FY2014 | Dec 31, 2014 | $26.20M | +35.6% |
| FY2013 | Dec 31, 2013 | $19.32M | +1.0% |
| FY2012 | Dec 31, 2012 | $19.13M | +3.5% |
| FY2011 | Dec 31, 2011 | $18.48M | +26.6% |
| FY2010 | Dec 31, 2010 | $14.60M | +6.9% |
| FY2009 | Dec 31, 2009 | $13.67M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.39M | – |
| Q1 FY2026 | Mar 31, 2026 | $7.18M | +8.0% |
| Q4 FY2025 | Dec 31, 2025 | $7.18M | +12.5% |
| Q3 FY2025 | Sep 30, 2025 | $13.76M | +46.1% |
| Q2 FY2025 | Jun 30, 2025 | -$1.14M | -116.8% |
| Q1 FY2025 | Mar 31, 2025 | $6.65M | -44.8% |
| Q4 FY2024 | Dec 31, 2024 | $6.38M | -45.5% |
| Q3 FY2024 | Sep 30, 2024 | $9.42M | -4.0% |
| Q2 FY2024 | Jun 30, 2024 | $6.79M | -23.2% |
| Q1 FY2024 | Mar 31, 2024 | $12.04M | +55.3% |
| Q4 FY2023 | Dec 31, 2023 | $11.71M | +44.5% |
| Q3 FY2023 | Sep 30, 2023 | $9.82M | -2.3% |
| Q2 FY2023 | Jun 30, 2023 | $8.84M | -10.0% |
| Q1 FY2023 | Mar 31, 2023 | $7.75M | -6.5% |
| Q4 FY2022 | Dec 31, 2022 | $8.10M | -32.9% |
| Q3 FY2022 | Sep 30, 2022 | $10.05M | +15.5% |
| Q2 FY2022 | Jun 30, 2022 | $9.82M | -12.0% |
| Q1 FY2022 | Mar 31, 2022 | $8.29M | -42.5% |
| Q4 FY2021 | Dec 31, 2021 | $12.07M | -25.5% |
| Q3 FY2021 | Sep 30, 2021 | $8.70M | -17.2% |
| Q2 FY2021 | Jun 30, 2021 | $11.16M | +33.2% |
| Q1 FY2021 | Mar 31, 2021 | $14.41M | +160.9% |
| Q4 FY2020 | Dec 31, 2020 | $16.22M | +35.8% |
| Q3 FY2020 | Sep 30, 2020 | $10.52M | -18.3% |
| Q2 FY2020 | Jun 30, 2020 | $8.38M | -4.8% |
| Q1 FY2020 | Mar 31, 2020 | $5.52M | -24.3% |
| Q4 FY2019 | Dec 31, 2019 | $11.94M | -14.2% |
| Q3 FY2019 | Sep 30, 2019 | $12.87M | +70.6% |
| Q2 FY2019 | Jun 30, 2019 | $8.81M | -13.4% |
| Q1 FY2019 | Mar 31, 2019 | $7.30M | -11.3% |
| Q4 FY2018 | Dec 31, 2018 | $13.91M | +110.4% |
| Q3 FY2018 | Sep 30, 2018 | $7.55M | -30.5% |
| Q2 FY2018 | Jun 30, 2018 | $10.16M | +310.3% |
| Q1 FY2018 | Mar 31, 2018 | $8.23M | +1.0% |
| Q4 FY2017 | Dec 31, 2017 | $6.61M | -25.1% |
| Q3 FY2017 | Sep 30, 2017 | $10.86M | +59.8% |
| Q2 FY2017 | Jun 30, 2017 | $2.48M | – |
| Q1 FY2017 | Mar 31, 2017 | $8.14M | – |
| Q4 FY2016 | Dec 31, 2016 | $8.82M | – |
| Q3 FY2016 | Sep 30, 2016 | $6.79M | – |
See a number that looks wrong?